CoChat

Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions

Jalleh, Ryan J, Rayner, Chris K, Hausken, Trygve, Jones, Karen L, Camilleri, Michael, Horowitz, Michael · 2024 · The Lancet Gastroenterology & Hepatology

The DOI matches its Crossref record; 73 of the 78 references it cites were found in a registry or an index.

Abstract

The availability of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as liraglutide and semaglutide, and a GLP-1 and glucose dependent insulinotropic polypeptide coagonist (tirzepatide) represents a paradigm shift in the management of both type 2 diabetes and obesity. There is now considerable attention, including in the public media, on the effect of both long-acting and short-acting GLP-1RAs to delay gastric emptying. Although slowed gastric emptying is integral to reducing post-prandial blood glucose responses in type 2 diabetes, marked slowing of gastric emptying might also increase the propensity for longer intragastric retention of food, with a consequent increased risk of aspiration at the time of surgery or upper gastrointestinal endoscopy. This Personal View summarises current knowledge of the effects of GLP-1 and GLP-1RAs on gastrointestinal physiology, particularly gastric emptying, and discusses the implications for the development of sound pre-operative or pre-procedural guidelines. The development of pre-procedural guidelines is currently compromised by the poor evidence base, particularly in relation to the effect of long-acting GLP-1RAs on gastric emptying. We suggest pre-procedural management pathways for individuals on GLP-1RA-based therapy and discuss priorities for future research.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(24)00188-2

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Cited by

See all 144

Metadata

Authors
Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M.
Affiliations
  • The University of Adelaide (AU)
  • Haukeland University Hospital (NO)
  • Mayo Clinic (US)
Corresponding author
Horowitz, Michael
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2024-10
Volume
9
Issue
10
Pages
957-964
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W4401230453
Cited by
144
References
78
Citations by year
2026: 68 · 2025: 67 · 2024: 9
FWCI
8.40
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet. Gastroenterology & hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
Keywords
GLP-1 receptor agonists, gastric emptying, aspiration risk, liraglutide, semaglutide, tirzepatide, upper gastrointestinal endoscopy, type 2 diabetes, obesity, postprandial blood glucose
MeSH terms
Liraglutide, Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Gastric Emptying, Humans, Hypoglycemic Agents, Obesity, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. https://app.cochat.ai/papers/10.1016/s2468-1253(24)00188-2
The paper
Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024). Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(24)00188-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.